Considerable improvement in survival for patients aged 60-84 years with high grade malignant gliomas-Data from the Swedish Brain Tumour Population-based Registry

Acta Oncologica

Volumn 52, Issue 5, 2013, Pages 1041-1043

  Asklund, Thomas ^a   Malmström, Annika ^b   Björ, Ove ^a   Blomquist, Erik ^c   Henriksson, Roger ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAPLASTIC OLIGODENDROGLIAL TUMOR; CANCER GRADING; CANCER REGISTRY; CANCER SURVIVAL; GERIATRIC CARE; GLIOBLASTOMA; GLIOMA; GROUPS BY AGE; HUMAN; LETTER; MAJOR CLINICAL STUDY; OLIGODENDROGLIA; PRIORITY JOURNAL; SWEDEN; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; MEDICAL CARE; VERY ELDERLY;

EID: 84891673491     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.754993     Document Type: Letter

References (13)

1. Louis DN , Ohgaki H, W iestler OD , C avenee WK, B urger PC , Jouvet A , et al . The 2007 WHO classifi cation of tumours of the central nervous system . Acta Neuropathol 2007; 114: 97-109 .
2. Malmstrom A , Gronberg BH, Marosi C, Stupp R , Frappaz D , Schultz H , et al . Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: The Nordic randomised, phase 3 trial . Lancet Oncol 2012; 13: 916-26 .
3. Wick W , P latten M , M eisner C , F elsberg J , T abatabai G , S imon M , et al . Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial . Lancet Oncol 2012; 13: 707-15 .
4. Laws E R , P arney I F, H uang W , A nderson F , M orris AM , A sher A , et al . Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project . J Neurosurg 2003; 99: 467-73 .
5. Sant M , Minicozzi P , L agorio S , Johannesen TB , Marcos-Gragera R , Francisci S . Survival of European patients with central nervous system tumors . Int J Cancer 2011; 131: 173-85 .
6. Keime-Guibert F , C hinot O, T aillandier L, C artalat-Carel S , Frenay M , Kantor G , et al . Radiotherapy for glioblastoma in the elderly . N Engl J Med 2007; 356: 1527-35 .
7. Stupp R , M ason W P , v an den Bent M J , W eller M , F isher B , Taphoorn MJ , et al . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma . N Engl J Med 2005; 352: 987-96 .
8. Hsieh JC, L esniak MS . S urgical management of high-grade gliomas . Expert Rev Neurother 2005; 5(6 Suppl): S33-9 .
9. Sanai N , B erger M S . O perative techniques for gliomas and the value of extent of resection . Neurotherapeutics 2009; 6: 478-86 .
10. Stieber V W , M ehta M P . A dvances in radiation therapy for brain tumors . Neurol Clin 2007; 25: 1005-33, ix .
11. Wick W, Weller M , P latten M , R oth P , W ick W . G eriatric neorooncology: From myth to biology . Curr Opin Neurol 2011; 24: 599-604 . Wick W
12. , H artmann C , E ngel C , S toffels M , F elsberg J , Stockhammer F , et al . NOA-4 Randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincriustine or temozolomide . J Clin Oncol 2009; 27: 5874-80 .
13. Holmberg LH . C an national cancer registration support clinical databases and clinical cancer research? Acta Oncol 2012; 51: 691-3 .